Christian Kanstrup Holm

Title: Christian Kanstrup Holm: Innovator in Gene Therapy and Immune Suppression

Introduction

Christian Kanstrup Holm is a notable inventor based in Lystrup, Denmark. He has made significant contributions to the fields of gene therapy and immune suppression, holding a total of 2 patents. His work focuses on innovative solutions for complex medical challenges, particularly in the treatment of fusion gene-related cancers.

Latest Patents

Holm's latest patents include groundbreaking inventions in CRISPR gene therapy. One of his patents describes a composition that comprises a first gRNA bound to an RNA-guided endonuclease, forming a first ribonucleoprotein complex. This first gRNA includes a targeting sequence that is complementary to a target sequence in an intron of a fusion gene. Additionally, a second gRNA is also included, which is bound to an RNA-guided endonuclease, forming a second ribonucleoprotein complex. This second gRNA has a targeting sequence complementary to a second target sequence in the 3′ downstream part of the fusion gene. These compositions have potential applications in treating fusion gene-related cancers. Another patent focuses on the use of immune suppressive domains as medicaments, specifically for immune suppression and the reduction of inflammation.

Career Highlights

Throughout his career, Christian Kanstrup Holm has worked with esteemed institutions such as Aarhus Universitet and Isd Immunotech ApS. His work in these organizations has allowed him to advance his research and contribute to significant innovations in his field.

Collaborations

Holm has collaborated with notable colleagues, including Magnus Stougaard and Shervin Bahrami, who have contributed to his research endeavors.

Conclusion

Christian Kanstrup Holm is a pioneering inventor whose work in gene therapy and immune suppression is making a substantial impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.